Dendritic cells (DCs) are sentinels of the immune system that uniquely prime naive cells and initiate adaptive immune responses. CD1c (BDCA-1) myeloid DCs (CD1c(+) mDCs) highly express
HLA-DR, have a broad
Toll-like receptor (TLR) repertoire, and secrete immune modulatory
cytokines. To better understand immune responses to
malaria, CD1c(+) mDC maturation and
cytokine production were examined in healthy volunteers before and after experimental intravenous Plasmodium falciparum
infection with 150- or 1,800-parasite-infected red blood cells (pRBCs). After either dose, CD1c(+) mDCs significantly reduced
HLA-DR expression in prepatent
infections. Circulating CD1c(+) mDCs did not upregulate
HLA-DR after pRBC or TLR
ligand stimulation and exhibited reduced CD86 expression. At peak
parasitemia, CD1c(+) mDCs produced significantly more
tumor necrosis factor (TNF), whereas
interleukin-12 (IL-12) production was unchanged. Interestingly, only the 1,800-pRBC dose caused a reduction in the circulating CD1c(+) mDC count with evidence of apoptosis. The 1,800-pRBC dose produced no change in T cell IFN-γ or
IL-2 production at peak
parasitemia or at 3 weeks posttreatment. Overall, CD1c(+) mDCs are compromised by P. falciparum exposure, with impaired
HLA-DR and CD86 expression, and have an increased capacity for TNF but not
IL-12 production. A first prepatent P. falciparum
infection is sufficient to modulate CD1c(+) mDC responsiveness, likely contributing to hampered effector T cell
cytokine responses and assisting parasite immune evasion.